share_log

藥明康德:註銷部分2019年A股激勵計劃授予的股票期權

WUXI APPTEC: CANCELLATION OF PART OF THE SHARE OPTIONS GRANTEDUNDER THE 2019 A SHARE INCENTIVE PLAN

HKEX ·  Jul 29 08:13

Summary by Moomoo AI

药明康德宣布,根據2019年A股激勵計劃,將註銷31,509份股票期權。這些期權原本授予7名激勵對象,但由於他們在第三個行權期屆滿前離職或未行權,因此作出註銷決定。該公司董事會已通過相關議案,並經監事會核查認為註銷行為合法有效,不會對公司經營業績產生重大影響。中國法律顧問方達律師事務所也確認註銷程序符合相關法律規定。此消息於2024年7月29日由公司董事長李革博士公告。
药明康德宣布,根據2019年A股激勵計劃,將註銷31,509份股票期權。這些期權原本授予7名激勵對象,但由於他們在第三個行權期屆滿前離職或未行權,因此作出註銷決定。該公司董事會已通過相關議案,並經監事會核查認為註銷行為合法有效,不會對公司經營業績產生重大影響。中國法律顧問方達律師事務所也確認註銷程序符合相關法律規定。此消息於2024年7月29日由公司董事長李革博士公告。
According to the 2019 A-share incentive plan, WuXi AppTec announces the cancellation of 31,509 stock options. These options were originally granted to seven incentive targets, but due to their resignation or failure to exercise the options before the third exercise period expired, the cancellation decision was made. The board of directors of the company has passed the relevant proposal, and the supervisory board has verified that the cancellation is legally valid and will not have a significant impact on the company's operations. Fangda Partners, the legal advisor in China, also confirmed that the cancellation procedure complies with relevant laws and regulations. This news was announced by Dr. Li Ge, the chairman of the board, on July 29, 2024.
According to the 2019 A-share incentive plan, WuXi AppTec announces the cancellation of 31,509 stock options. These options were originally granted to seven incentive targets, but due to their resignation or failure to exercise the options before the third exercise period expired, the cancellation decision was made. The board of directors of the company has passed the relevant proposal, and the supervisory board has verified that the cancellation is legally valid and will not have a significant impact on the company's operations. Fangda Partners, the legal advisor in China, also confirmed that the cancellation procedure complies with relevant laws and regulations. This news was announced by Dr. Li Ge, the chairman of the board, on July 29, 2024.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more